| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5643626 | Sleep Medicine | 2017 | 17 Pages |
Abstract
Our cases suggest that sodium oxybate can be an effective add-on option for the treatment of idiopathic RBD refractory to conventional therapies. The lack of improvement of polysomnographic parameters suggests caution in considering only polysomnographic data as endpoints in the assessment of the efficacy of therapies for RBD, and that long-term home-based assessment seems a promising tool.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Keivan Kaveh Moghadam, Fabio Pizza, Alberto Primavera, Raffaele Ferri, Giuseppe Plazzi,